Microvisk-Logo

 

 

 

Appointment flags US market move:

 

Allison Remensperger has joined Microvisk as Manager, US Operations.

The appointment is a key step to take Microvisk towards and beyond securing US Food and Drug Administration (FDA) approval to mandate commercial launch of the company’s CoagMax® PT/INR testing system across US healthcare markets.

Allison

 

Allison was most recently Operations Manager with Critical Diagnostics. Inc. overseeing quality, regulatory, manufacturing, technical support and logistics functions.

Microvisk CEO Jim Thurlow commented: “Following accreditation of our testing system for UK/EU sales, the US market is a key future objective.

 “Allison brings to Microvisk a special combination of experience in diagnostics, drug development, support services and the US regulatory journey to market approval.”

 

Allison’s prior career included roles with Biogen IDEC and Synbiotics (now Pfizer Animal Health).

After gaining a BSc. In Environmental Toxicology from the University of California Allison began her career as an Investigator in the San Diego County Medical Examiner’s office.

She lives with her husband and daughter in San Diego.